A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Recientemente, se han realizado intentos de aislar exclusivamente los islotes que producen insulina en el páncreas del donante y de inyectarlos directamente al torrente sanguíneo de un paciente diabético para que se alojen en los tejidos y produzcan insulina.
El "trasplante de islotes de Langerhans" es todavía un procedimiento experimental, pero podría algún día ofrecer un tratamiento para la diabetes, pues a diferencia de un trasplante total de páncreas, no requiere de cirugía mayor.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885